Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in HUMA — Humacyte, Inc.

CIK 1390777 NEW YORK, NY
Back to HUMA Full portfolio

Position in HUMA

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$43,557
-$170,962 QoQ
Shares Held
55,844
-84.2% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 163 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HUMA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. HUMA ranks #295 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in HUMA

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $43,557 55,844
2026-03-31 $214,519 353,410
2025-12-31 $330,343 343,751
2025-09-30 $560,898 322,356
2025-06-30 $624,069 298,598
2025-03-31 $322,920 189,397
2024-12-31 $971,517 192,380
2024-09-30 $1,056,523 194,214
2024-06-30 $1,219,261 254,013
2024-03-31 $485,413 156,082
2023-12-31 $500,838 176,352
2023-09-30 $774,713 264,408
2023-06-30 $746,762 261,106
2023-03-31 $810,120 262,175
2022-12-31 $564,861 267,707
2022-09-30 $227,469 69,776
2022-06-30 $180,530 56,240
2022-03-31 $188,092 26,642